Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. David P. PerryPresident and CEO361,3060.84%2014-03-04
Mr. Paul L. BernsPresident and CEO325,0000.76%2014-12-26
Dr. Jacob J. Plattner, PhDSenior VP, Research99,6000.23%2014-01-27
Mr. Geoffrey M. ParkerExecutive Vice President & CFO87,0000.2%2014-09-05
Vincent IppolitoEVP & Chief Commercial Officer72,0000.17%2014-03-06
Paul H. KlingensteinDirector58,0010.14%2010-11-30
Ryan T. SullivanN/A25,000less than 0.1%2014-04-28
Sanjay ChandaSVP, Drug Development23,068less than 0.1%2014-12-19
Dr. Lee T. Zane, M.D.,M.A.S.SVP and Chief Medical Officer21,291less than 0.1%2014-12-29
Ms. Carmen R. RodriguezSnr VP Reg Afrs & Qual. Assur.6,000less than 0.1%2014-04-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Maples Kirk RSVP, Program Management2015-01-02Sell6004,200$31.9619.217.65Link
Plattner Jacob jSenior VP, Research2015-01-02Sell6,87558,350$32.09220.617.17Link
BERNS PAUL LPresident and CEO
(Click for the stocks that their CEOs have bought)
2014-12-26Sell25,000325,000$30.82770.522Link
Shapiro LucyDirector2014-12-12Sell289,6850$35.1110170.87.09Link
Zane LeeSVP and Chief Medical Officer2014-12-11Sell4,9007,000$36.09176.84.18Link
Maples Kirk RSVP, Program Management2014-12-09Sell60,0004,800$36.522191.22.96Link
Plattner Jacob jSenior VP, Research2014-12-01Sell6,87566,125$33.34229.212.78Link
Maples Kirk RSVP, Program Management2014-12-01Sell6004,900$33.382012.64Link
Chanda SanjaySVP, Drug Development2014-11-26Sell5,0008,995$351757.43Link
Maples Kirk RSVP, Program Management2014-11-03Sell6005,400$29.117.529.21Link
Plattner Jacob jSenior VP, Research2014-11-03Sell6,87572,100$29.32201.628.24Link
Plattner Jacob jSenior VP, Research2014-10-01Sell6,87578,975$24.47168.253.66Link
Maples Kirk RSVP, Program Management2014-10-01Sell6006,000$23.8514.357.65Link
Hove Anders DDirector2014-09-26Sell20,0002,725,535$2550050.4Link
Hove Anders DDirector2014-09-19Sell740,0003,484,035$24.8718403.851.19Link
Hove Anders DDirector2014-09-16Sell90,0003,560,535$24.992249.150.46Link
Chanda SanjaySVP, Drug Development2014-09-10Sell10,0009,042$24.25242.555.05Link
Parker Geoffrey M.Executive Vice President & CFO2014-09-08Buy6,590170,000$21.82143.872.32Link
Maples Kirk RSVP, Program Management2014-09-02Sell33,87930,619$23.3789.461.37Link
Plattner Jacob jSenior VP, Research2014-09-02Sell6,87585,850$23.34160.561.1Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK